Senate passes bill for FTC scrutiny of biosimilar ‘pay-for-delay’ deals
The tweak was part of the Patient Right to Know Drug Prices Act, which … Robert Cerwinski, an intellectual property lawyer at the law firm Goodwin …
In: PATENT NEWS
The tweak was part of the Patient Right to Know Drug Prices Act, which … Robert Cerwinski, an intellectual property lawyer at the law firm Goodwin …
In: PATENT NEWS
And so a patent that simply describes that relation sets forth a natural law.” In Mayo the asserted claim only recited administering a thiopurine drug to a …
In: PATENT NEWS
Addiction Drug Developer Adial Pharmaceuticals Successfully Passes Patent Opposition Period in Europe for AD04 in … The Bakersfield Californian Adial Pharmaceuticals (ADIL) Reports ‘No Challenges to European Patent’ for AD04 in Alcohol Use Disorder StreetInsider.com Full coverage
In: PATENT NEWS
ChromaDex and Dartmouth College File Patent Infringement Lawsuit Against Elysium Health Nasdaq Full coverage
In: PATENT NEWS
Qualcomm takes another shot at iPhone sales ban in patent proceedings this week The San Diego Union-Tribune Qualcomm, Apple kick off second trial seeking iPhone import ban Reuters Full coverage
In: PATENT NEWS
Fed. Circ. Upholds AT&T Quick Win In Ethernet Patent Case Law360 Full coverage
In: PATENT NEWS
During oral arguments this month at the Federal Circuit, Rudolph A. Telscher Jr. of Husch Blackwell LLP, an attorney for Emerson, said the district …
In: PATENT NEWS
The agency also declined to review the administrative law judge’s finding that U.S. Patent Number 6,809,490 was invalid, affirming that decision.
In: PATENT NEWS
Gleevec Buyers Say 1st Circ.’s Dismissal Misread Patent Law. Access this news story on Law360. Comment. United States. Copyright © 2018 …
In: PATENT NEWS
s Dismissal Misread Patent Law. September 17, 2018 admin. Buyers of the leukemia drug Gleevec urged a First Circuit panel on Friday to rehear its …
Designed by Industrial Action
Copyright © 2025 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION